MARKET

GSK

GSK

GSK
NYSE

Real-time Quotes | Nasdaq Last Sale

43.49
-0.06
-0.14%
Pre Market: 42.74 -0.15 -0.35% 07:16 02/20 EST
OPEN
43.55
PREV CLOSE
43.55
HIGH
43.79
LOW
43.48
VOLUME
3.54M
TURNOVER
--
52 WEEK HIGH
48.25
52 WEEK LOW
38.43
MARKET CAP
108.50B
P/E (TTM)
17.67
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of GSK and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

GSK News

  • FDA Approved 1,014 Generic Drugs in 2019
  • MotleyFool.com.16h ago
  • Top Research Reports for Facebook, Netflix & NextEra Energy
  • Zacks.19h ago
  • Is Dynavax Technologies Stock a Buy?
  • MotleyFool.com.21h ago
  • China’s tourism, automotive industries sink amid COVID-19 outbreak
  • MarketWatch.21h ago

More

Industry

Pharmaceuticals
-0.01%
Pharmaceuticals & Medical Research
+0.22%

Hot Stocks

Name
Price
%Change

About GSK

GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.
More

Webull offers GlaxoSmithKline plc (ADR) (GSK) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.